Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Mittendorf

Showing results (1-10 of 399) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2023
Peritumoral Lidocaine Injection: A Low-Cost, Easily Implemented Intervention to Improve Outcomes in Early-Stage Breast CancerTessa Higgins, Elizabeth A Mittendorf
Annals of Surgical Oncology|August 17, 2021
ASO Author Reflections: Racial and Socioeconomic Disparities in Breast Cancer Mortality Persist Beyond Tumor BiologyOlga Kantor, Elizabeth A Mittendorf
JAMA Oncology|September 13, 2019
Lack of Robust Prognostic Biomarkers for Immunotherapy in Breast Cancer-Adverse Events-In ReplySylvia Adams, Elizabeth A Mittendorf
Annals of Surgical Oncology|April 23, 2014
Breast cancer biology: implications for local-regional therapyElizabeth A Mittendorf, Isabelle Bedrosian
Expert Review of Vaccines|December 22, 2009
Mechanisms of T-cell inhibition: implications for cancer immunotherapyElizabeth A Mittendorf, Padmanee Sharma
Oncology (Williston Park, N.Y.)|September 23, 2011
Locoregional treatment of breast cancer: where to next?Elizabeth A Mittendorf, Benjamin D Smith
Journal of Surgical Oncology|February 19, 2005
Parathyroid carcinomaElizabeth A Mittendorf, Christopher R McHenry
Annals of Surgical Oncology|August 18, 2017
All HER2-Positive Tumors are not Created EqualElizabeth A Mittendorf, Mariana Chavez-MacGregor
JAMA Oncology|August 29, 2024
Neoadjuvant Immunotherapy-From Trials to PracticeElizabeth A Mittendorf, Sara M Tolaney
Vaccine|October 4, 2015
Cancer vaccines in the new era of cancer immunotherapyKeith L Knutson, Elizabeth A Mittendorf
Pageof 40

Showing results (1-10 of 399) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2023
Peritumoral Lidocaine Injection: A Low-Cost, Easily Implemented Intervention to Improve Outcomes in Early-Stage Breast CancerTessa Higgins, Elizabeth A Mittendorf
Annals of Surgical Oncology|August 17, 2021
ASO Author Reflections: Racial and Socioeconomic Disparities in Breast Cancer Mortality Persist Beyond Tumor BiologyOlga Kantor, Elizabeth A Mittendorf
JAMA Oncology|September 13, 2019
Lack of Robust Prognostic Biomarkers for Immunotherapy in Breast Cancer-Adverse Events-In ReplySylvia Adams, Elizabeth A Mittendorf
Annals of Surgical Oncology|April 23, 2014
Breast cancer biology: implications for local-regional therapyElizabeth A Mittendorf, Isabelle Bedrosian
Expert Review of Vaccines|December 22, 2009
Mechanisms of T-cell inhibition: implications for cancer immunotherapyElizabeth A Mittendorf, Padmanee Sharma
Oncology (Williston Park, N.Y.)|September 23, 2011
Locoregional treatment of breast cancer: where to next?Elizabeth A Mittendorf, Benjamin D Smith
Journal of Surgical Oncology|February 19, 2005
Parathyroid carcinomaElizabeth A Mittendorf, Christopher R McHenry
Annals of Surgical Oncology|August 18, 2017
All HER2-Positive Tumors are not Created EqualElizabeth A Mittendorf, Mariana Chavez-MacGregor
JAMA Oncology|August 29, 2024
Neoadjuvant Immunotherapy-From Trials to PracticeElizabeth A Mittendorf, Sara M Tolaney
Vaccine|October 4, 2015
Cancer vaccines in the new era of cancer immunotherapyKeith L Knutson, Elizabeth A Mittendorf
Pageof 40